Hospira Adds Orchid Generic Antibiotic Unit For $400M
Building on an existing relationship, Hospira Inc. has added Orchid Chemicals & Pharmaceuticals Ltd.'s generic injectable antibiotics business in a deal valued at about $400 million....To view the full article, register now.
Already a subscriber? Click here to view full article